Editor

8393 POSTS
0 COMMENTS

FDA Grants Breakthrough Designation to Sofi-cel for Relapsed/Refractory T-Cell ALL/LBL

The U.S. Meals and Drug Administration (FDA) has granted breakthrough remedy designation to an investigational CAR-T cell remedy, soficabtagene geleucel (Sofi-cel), for...

CAR-NK Reveals Lengthy-Time period Response in Waldenström Non-Hodgkin Lymphoma

Sufferers with Waldenström Non-Hodgkin lymphoma within the U.S. achieved sturdy full responses of as much as 15 months utilizing a chemotherapy-free CD19...

Key Affected person Takeaways From the 2026 ASCO GI Cancers Symposium

Throughout the 2026 ASCO Gastrointestinal (GI) Cancers Symposium, CURE was stay on website, the place we spoke immediately with conferencegoers, oncologists and...

Breast Most cancers Survivor Underwent Nerve-Sparing Process She Developed

When San Francisco-based surgeon Dr. Anne Peled determined to bear a sensation-preserving mastectomy following her second analysis of breast most cancers, she...

Adjuvant Temozolomide Improves Survival in 1p/19q Non-Co-Deleted Glioma

New analysis from the worldwide CATNON trial exhibits that sufferers with newly recognized 1p/19q non-co-deleted anaplastic astrocytomas who obtained radiotherapy adopted by...

Editor

8393 POSTS
0 COMMENTS
spot_img